01—History
Net Income History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2026. Drag across the bars to change the range.
- $782.6M
5 older moves run past ±150% (largest +347.4%); point at, tap or drag across the bars to read one.
02—Ledger
Net Income, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $782.6M | +50.1% | 10-K | |
| FY2025 | $521.3M | +150.9% | 10-K | |
| FY2023 | $207.8M | +14.0% | 10-K | |
| FY2022 | $182.3M | −21.1% | 10-K | |
| FY2021 | $231.1M | −28.0% | 10-K | |
| FY2020 | $321.0M | −53.5% | 10-K | |
| FY2018 | $690.1M | +347.4% | 10-K | |
| FY2017 | $154.2M | +319.6% | 10-K | |
| FY2016 | −$70.2M | +56.6% | 10-K | |
| FY2015 | −$161.7M | +38.1% | 10-K | |
| FY2014 | −$261.3M | −9.7% | 10-K | |
| FY2013 | −$238.2M | −63.9% | 10-K | |
| FY2012 | −$145.3M | −292.0% | 10-K | |
| FY2011 | $75.7M | +182.0% | 10-K | |
| FY2010 | −$92.3M | +31.7% | 10-K | |
| FY2009 | −$135.2M | — | 10-K |
03—Questions
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is Exelixis's current net income?
Exelixis (EXEL) annual net income for 2026 was $782.6M, a 50.12% increase from 2025. Exelixis net income for the quarter ending October 2, 2026 was $218.1M.
What was Exelixis's net income in 2025?
Exelixis annual net income for 2025 was $521.3M, a 150.87% increase from 2023.
What was Exelixis's net income in 2023?
Exelixis annual net income for 2023 was $207.8M, a 13.99% increase from 2022.
What is Exelixis's 5-year net income CAGR?
Exelixis net income grew at a compound annual growth rate (CAGR) of 27.63% from FY2021 to FY2026, going from $231.1M to $782.6M over 5 years.
- Company
- Exelixis
- Ticker
- EXEL
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)